Levofloxacin might be safe to use for OSCC patients

dc.contributor.author	Aydemir, L.
dc.contributor.author	Iplik, E.S.
dc.contributor.author	Ertugrul, B.
dc.contributor.author	Kasarci, G.
dc.contributor.author	Atas, M.N.
dc.contributor.author	Ulusan, M.
dc.contributor.author	Ergen, A.
dc.contributor.author	Cakmakoglu, B.
dc.date.accessioned	2021-12-21T08:40:30Z
dc.date.available	2021-12-21T08:40:30Z
dc.date.issued	2021
dc.identifier.issn	13570560
dc.identifier.uri	https://doi.org/10.1007/s12032-021-01538-2
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1018
dc.description.abstract	Oral squamous cell carcinoma patients are exhausted against the powerful chemotherapies, radiotherapies after the surgery, and their immune system is devastated during the process and antibiotic usage become inescapable. Although prescribing an antibiotic
dc.description.sponsorship	The work was supported by Scientific Research Projects Coordination Unit of Istanbul University in Istanbul, Turkey. Project ID Number: 24114.
dc.language.iso	English
dc.publisher	Springer
dc.title	Levofloxacin might be safe to use for OSCC patients
dc.type	Article
dc.relation.journal	Medical Oncology
dc.identifier.issue	8
dc.identifier.volume	38
dc.identifier.doi	10.1007/s12032-021-01538-2
dc.relation.issue	8
dc.relation.volume	38